Skip to contentP
Petmed Express Inc
P
PETSPetmed Express Inc Q3 2025 · 10-Q
Revenue$51.96M$51.96M−18.4% vs Q3 2024 Net Income-$707.00K-$707.00KN/M vs Q3 2024 EPS Diluted-$0.03-$0.03N/M vs Q3 2024 Gross Profit$16,131,000−17.0% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Petmed Express Inc · CIK 1040130 · Engraved from SEC EDGAR
Operating Cash Flowderived-$1,166,000N/M Free Cash Flowderived-$1,943,000N/M Margins · derivedGross margin31.0%+0.5 pt vs Q3 2024
Operating margin-0.9%+4.0 pt vs Q3 2024
Net margin-1.4%+1.8 pt vs Q3 2024
ended Dec 31, 2024 · filed Feb 10, 2025 · 41 d after period end